Transcriptomics

Dataset Information

0

Time-dependent enhancement of mRNA vaccines by 4-1BB costimulatory antibodies


ABSTRACT: mRNA vaccines have demonstrated efficacy against COVID-19. However, concerns regarding waning immunity and breakthrough infections have motivated the development of next-generation vaccines with enhanced efficacy. In this study, we investigated the impact of 4-1BB costimulation on immune responses elicited by mRNA vaccines in mice. We first vaccinated mice with an mRNA vaccine encoding the SARS-CoV-2 spike antigen like the Moderna and Pfizer-BioNTech vaccines, followed by administration of 4-1BB costimulatory antibodies at various times post-vaccination. Administering 4-1BB costimulatory antibodies during the priming phase did not enhance immune responses. However, administering 4-1BB costimulatory antibodies after 96 hours elicited a significant improvement in CD8 T cell responses, leading to enhanced protection against breakthrough infections. A similar improvement in immune responses was observed with multiple mRNA vaccines, including vaccines against common cold coronavirus, human immunodeficiency virus (HIV), and arenavirus. These findings demonstrate a time-dependent effect by 4-1BB costimulation and provide insights for developing improved mRNA vaccines.

ORGANISM(S): Mus musculus

PROVIDER: GSE260817 | GEO | 2024/09/04

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2016-06-14 | E-GEOD-79475 | biostudies-arrayexpress
2016-06-14 | GSE79475 | GEO
2024-05-24 | PXD042585 | Pride
2015-04-09 | E-GEOD-65856 | biostudies-arrayexpress
2016-04-19 | GSE68329 | GEO
2023-01-30 | GSE223087 | GEO
2021-11-19 | GSE140720 | GEO
2022-08-19 | GSE211352 | GEO
2024-05-08 | GSE254546 | GEO
2023-05-28 | GSE231443 | GEO